Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Muscarinic acetylcholine receptor M3 | ||
Ligand | BDBM50522817 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1888526 (CHEMBL4390203) | ||
Ki | 0.440000±n/a nM | ||
Citation | Yamashita, Y; Tanaka, KI; Yamakawa, N; Asano, T; Kanda, Y; Takafuji, A; Kawahara, M; Takenaga, M; Fukunishi, Y; Mizushima, T Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity. Bioorg Med Chem27:3339-3346 (2019) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Muscarinic acetylcholine receptor M3 | |||
Name: | Muscarinic acetylcholine receptor M3 | ||
Synonyms: | ACM3_HUMAN | CHRM3 | Cholinergic, muscarinic M3 | Muscarinic Receptors M3 | Muscarinic receptor M3 | RecName: Full=Muscarinic acetylcholine receptor M3 | ||
Type: | Enzyme | ||
Mol. Mass.: | 66151.03 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P20309 | ||
Residue: | 590 | ||
Sequence: |
| ||
BDBM50522817 | |||
n/a | |||
Name | BDBM50522817 | ||
Synonyms: | CHEMBL4448944 | ||
Type | Small organic molecule | ||
Emp. Form. | C30H34BrNO3 | ||
Mol. Mass. | 536.5 | ||
SMILES | [Br-].OC(C(=O)OC1C[N+]2(CCCc3ccccc3)CCC1CC2)(c1ccccc1)c1ccccc1 |(82.27,-32.47,;72.86,-34.32,;74.2,-35.09,;75.54,-35.86,;75.54,-37.4,;76.87,-35.08,;78.21,-35.85,;79.54,-35.07,;80.86,-35.85,;82.19,-35.08,;83.53,-35.85,;84.86,-35.09,;86.19,-35.86,;86.19,-37.4,;87.52,-38.17,;88.85,-37.4,;88.85,-35.86,;87.52,-35.09,;80.87,-37.39,;79.54,-38.15,;78.21,-37.39,;79.7,-37.19,;79.35,-36.14,;74.2,-33.55,;75.53,-32.78,;75.53,-31.24,;74.19,-30.47,;72.85,-31.26,;72.86,-32.79,;72.87,-35.86,;71.54,-35.09,;70.21,-35.86,;70.21,-37.41,;71.56,-38.17,;72.88,-37.39,)| | ||
Structure |